<DOC>
	<DOC>NCT01581957</DOC>
	<brief_summary>Specifically designed enteral formulations may improve the gastrointestinal tolerance during early enteral nutrition in the critically ill patient. This pilot trial will permit testing the design of the full-scale study providing valuable data on the expected effect of the formulation, the variability, thus helping to better estimate the required sample size.</brief_summary>
	<brief_title>Pilot Study on Gastro-intestinal (GI) Enteral Nutrition (EN) Tolerance in Intensive Care Unit Patients</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<criteria>Male or female older than 18 years of age All ICU patients Expected ICU stay superior or equal to 5 days Anticipated to receive tube feeding for at least 3 days Informed consent obtained from patient or close relative Contraindication to enteral nutrition or to the placement of an enteral feeding tube On enteral nutrition with superior or equal to 75% of caloric goal administered Restriction in full intestinal support including protein administration Parenteral nutrition of any kind unless due to enteral nutrition intolerance History of allergy or intolerance to the study product components (test or control product) Currently under therapeutic limitations. Non functional GI tract Unwilling or unable to comply with study treatments Currently participating or having participated in another clinical, interventional trial during the last month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Enteral nutrition, critically ill patients</keyword>
</DOC>